Slides
Page 1
Third Quarter 2026 Results November 3, 2026
Page 2
Speakers Samantha Stoddard CFO Bill Christensen CEO
Page 3
Disclosures 3 Certain statements in this presentation, including our guidance and business strategies, are forward- looking statements that involve risk, uncertainty and assumptions, and are based on information as of November 3, 2026. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, you should review our Annual Report on Form 10-K, Form 10-Qs filed in 2026 and our other filings with the U.S. Securities and Exchange Commission. During this presentation, we will discuss certain non-GAAP financial measures including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted EPS, Free Cash Flow and Net Debt Leverage. A reconciliation of non-GAAP financial measures to their nearest comparable GAAP financial measures is available at the end of this presentation and our earnings release. Due to rounding, numbers presented throughout this presentation may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Page 4
Third Quarter 2026 Summary ▪ Sales of $799 million ▪ Adjusted EBITDA of $54 million ❑ 6.8% of sales ▪ Concluded strategic review of Europe ▪ Launched debt refinancing tender / exchange Third Quarter 2026 BUILDING MOMENTUM AND FINANCIAL FLEXIBILITY 4
Page 5
Q3 2026 Financial Results
Page 6
MARGIN EXPANSION ON SLIGHT REVENUE DECLINE Q3 2026 Financial Summary USD in Millions Net Revenue Core Revenue down (1%) driven by lower volume / mix Adjusted EBITDA Adjusted EBITDA Margin Productivity gains & cost savings driving higher earnings 6 $809 $799 Q3 2025 Q3 2026 -1% $44 $54 Q3 2025 Q3 2026 +23% 5.5% Q3 2025 6.8% Q3 2026 +130 bps
Page 7
Q3 2025 Price Volume / Mix Foreign Exchange Q3 2026 $809 $11 ($19) ($3) $799 VOLUME / MIX HEADWINDS CONTINUE TO STABILIZE Q3 2026 Revenue Bridge 7 USD in Millions Core Revenue (1%) Note: Amounts do not foot due to rounding
Page 8
PRICE / COST HEADWINDS OFFSET BY COST REDUCTIONS AND TARIFF REFU NDS Q3 2026 Adjusted EBITDA Bridge 8 USD in Millions Q3 2025 Price / Cost Volume / Mix Productivity SG&A / Other Income / FX Q3 2026 $44 ($14) ($6) $10 $7 $54 Tariff Refund $12 Adj. Margin 5.5% Adj. Margin 6.8% Note: Amounts do not foot due to rounding
Page 9
Q3 2026 Segment Results USD in Millions Segment Highlights ▪ North America revenue down (3%) year-over-year • Core revenue down (3%) • Mainly driven by lower volume ▪ Europe revenue up 2% year-over-year • Higher price, partially offset by FX headwinds North America Q3 2026 Q3 2025 (Prior Year) Q2 2026 (Previous Quarter) Net Revenue $530 $546 $529 Adjusted EBITDA $48 $38 $41 Adjusted EBITDA margin 9.1% 6.9% 7.7% Europe Q3 2026 Q3 2025 (Prior Year) Q2 2026 (Previous Quarter) Net Revenue $269 $263 $289 Adjusted EBITDA $15 $16 $13 Adjusted EBITDA margin 5.6% 6.1% 4.6% 9
Page 10
Outlook
Page 11
Market Outlook 2026 North America Europe Mid Single-Digit* Volume Decline Low Single-Digit* Volume Decline New single-family construction Down mid single-digits* Repair & Remodel Down mid single-digits Multi-family & Canada Approximately Flat Residential construction Down low single-digits* Commercial projects Down low single-digits* MARKET OUTLOOK SOFTER IN BOTH REGIONS 11 *Change from prior Quarter
Page 12
MAINTAINING GUIDANCE 2026 Guidance 12 Net Revenue $3.1B to $3.2B Core Revenue Down (2%) to (5%) Adjusted EBITDA $120M to $150M Operating Cash Flow ~$10M Cap Ex ~$85M Free Cash Flow ~($75M)
Page 13
SHARE RECOVERY OFFSETTING MARKET AND PRICE / COST HEADWINDS 2026 Guidance Bridge 13 Adjusted EBITDA; USD in Millions $118 $135 $85 $35 2025 EBITDA Market Volume / Mix Share Loss Volume / Mix Price / Cost Rightsizing Business / Base Productivity Transformation Carryover Other / FX 2026 EBITDA Guidance Midpoint ($30) ($5) ($60) ($8)
Page 14
North American On-Time, In-Full Rates (OTIF) RECOVERY FOLLOWING SUMMER WILDFIRES 14 Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Mar-26 Apr-26 May-26 Jun-26 Jul-26 Aug-26 Sep-26 Oct-26 90%
Page 15
DISCIPLINED EXECUTION DRIVING RESULTS JELD-WEN Next Steps 15 Operational Improvements Cost Management
Page 16
Appendix
Page 17
Key Assumptions for 2026 Key Assumption 2026 Estimate Depreciation and Amortization ~$115 Interest Expense, net $80 to $85 Cash Taxes Paid $7 to $15 Diluted Share Count ~86 million USD in Millions ✓ Full-year EBITDA split ~35% in 1H ✓ Price / Cost negative vs 2025 ✓ Foreign exchange translation tailwinds due to weaker US Dollar ✓ No share repurchases, acquisitions or divestitures included in outlook 17
Page 18
Q3 2026 Net Revenue Walk 18 Q3 2026 JELD-WEN North America Europe Price 1% -% 4% Volume / Mix (2%) (3%) (1%) Core Revenue Growth (1%) (3%) 3% FX -% -% (1%) Total (1.4%) (3.0%) 2.1%
Page 19
YTD 2025 Price Volume / Mix Court-Ordered Divestiture Foreign Exchange YTD 2026 $2,409 $18 ($118) ($7) $36 $2,338 LOWER VOLUME / MIX FROM MARKET HEADWINDS Q3 YTD 2026 Revenue Bridge 19 USD in Millions Core Revenue (4%)
Page 20
PRICE / COST HEADWINDS FROM COMPETITIVE MARKET Q3 YTD 2026 Adjusted EBITDA Bridge 20 USD in Millions YTD 2025 Price / Cost Volume / Mix Productivity SG&A / Other Income YTD 2026 $105 ($64) ($33) $68 $15 $103 Tariff Refund $13 Adj. Margin 4.4% Adj. Margin 4.4%
Page 21
Balance Sheet and Cash Flow USD in Millions Cash Flow (YTD) Q3 2026 Q3 2025 Net cash used in operating activities ($73) ($38) Capital Expenditures(1) ($57) ($104) Free Cash Flow(2) ($130) ($142) Balance Sheet September 26, 2026 December 31, 2025 Total Debt $1,281 $1,173 Cash $97 $136 Net Debt(3) $1,184 $1,037 Divided by trailing twelve months Adjusted EBITDA from continuing operations(4) $116 $118 Net Debt Leverage(3) 10.3x 8.8x Liquidity(5) $269 $485 (1) Includes purchases of property, equipment, and intangible assets. (2) Free Cash Flow is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation ofFree Cash Flow, refer to the Q3 2026 earnings release. (3) Net Debt and Net Debt Leverage are financial measures that are not calculated in accordance with GAAP. For a discussion of our presentation of Net Debt Leverage refer to the Q3 2026 earnings release. (4) Trailing twelve months Adjusted EBITDA from continuing operations for both periods. Adjusted EBITDA from continuing operations is a financial measure that is not calculated in accordance with GAAP. For a discussion of our presentation of Adjusted EBITDA from continuing operations, refer to the Q3 2026 earnings release. Additionally, refer to the calculation of trailing twelve months Adjusted EBITDA from continuing operations included later in this presentation. (5) Liquidity includes cash and cash equivalents, as well as availability from undrawn committed credit facilities. 21
Page 22
Adjusted Net Income (Loss) From Continuing Operations Reconciliation (1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed later in this presentation. (2) Other special items not core to ongoing business activity include: (i) for the three months ended September 26, 2026, impairment charges of $2.5million recognized in connection with the Company’s North America equipment capacity optimization review and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement.; (ii) for the nine months ended September 26, 2026, impairment charges of $5.6million recognized in connection with the Company’s North America equipment capacity optimization review, $3.0 million of impairment and other related charges related to windows manufacturing technology, and $1.8 million of impairment charges related to logistics technology, each of which was determined to have no future use, $2.5 million related to post-production expenses for closed facilities in North America, $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture, $2.0 million related to build-out costs for a new production site in the United Kingdom in our Europe reporting segment, and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement. (3) Except for non-deductible goodwill impairments, adjustments to net income (loss) from continuing operations and adjusted net income (loss) per share from continuing operations are tax-effected using the applicable jurisdictional statutory tax rate. (4) Tax special items for the three and nine months ended September 26, 2026, primarily included nominal tax expense and $3.2 million of tax expense, respectively, attributable to domestic share-based compensation, fully offset by a nominal tax benefit and $3.2 million of tax benefit, respectively, related to the valuation allowance recorded against our U.S. tax attributes, and tax expense of $0.3 million and $1.4 million, respectively, due to changes in UTPs from ongoing audits. Tax special items for the three and nine months ended September 27, 2025, were primarily driven by valuation expense recorded against our U.S. tax attributes of $115.0 million and $129.2 million, respectively. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. USD in Millions Three Months Ended Nine Months Ended (amounts in millions) September 26, 2026 September 27, 2025 September 26, 2026 September 27, 2025 Loss from continuing operations, net of tax $ (17.2) $ (367.6) $ (125.6) $ (580.0) Special items:(1) Net legal and professional expenses and settlements 1.3 5.8 16.9 26.3 Goodwill impairment — 196.9 — 334.6 Restructuring and asset-related charges, net 12.7 8.8 18.7 32.2 M&A related costs, net (2.4) 2.4 8.6 1.9 Net gain on sale of business, property, and equipment (0.1) — (0.1) (2.8) Loss on extinguishment and refinancing of debt — — — 0.2 Share-based compensation expense 4.2 4.3 11.6 11.9 Other special items(2) 5.8 (0.6) 20.6 3.3 Tax impact of special items(3) — 10.5 — — Tax special items(4) 0.3 122.3 1.4 137.7 Adjusted Net Income (Loss) from continuing operations $ 4.4 $ (17.3) $ (48.0) $ (34.7) 22
Page 23
Adjusted Net Income (Loss) Per Share From Continuing Operations Reconciliation Three Months Ended Nine Months Ended September 26, 2026 September 27, 2025 September 26, 2026 September 27, 2025 Diluted loss per share from continuing operations $ (0.20) $ (4.30) $ (1.45) $ (6.81) Special items:(1) Net legal and professional expenses and settlements 0.01 0.07 0.20 0.31 Goodwill impairment — 2.31 — 3.93 Restructuring and asset-related charges, net 0.14 0.10 0.22 0.38 M&A related costs, net (0.03) 0.03 0.10 0.02 Net gain on sale of business, property, and equipment — — — (0.03) Share-based compensation expense 0.05 0.05 0.13 0.14 Other special items(2) 0.07 (0.01) 0.24 0.04 Tax impact of special items(3) — 0.12 — — Tax special items(4) — 1.43 0.02 1.62 Adjusted Net Income (Loss) per share from continuing operations $ 0.05 $ (0.20) $ (0.56) $ (0.41) Weighted average diluted shares 87,330,039 85,392,703 86,321,998 85,206,011 Less: Effect of dilutive securities 575,328 — — — Weighted average basic shares 86,754,711 85,392,703 86,321,998 85,206,011 23 (1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed later in this presentation. (2) Other special items not core to ongoing business activity include: (i) for the three months ended September 26, 2026, impairment charges of $2.5million recognized in connection with the Company’s North America equipment capacity optimization review and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement.; (ii) for the nine months ended September 26, 2026, impairment charges of $5.6million recognized in connection with the Company’s North America equipment capacity optimization review, $3.0 million of impairment and other related charges related to windows manufacturing technology, and $1.8 million of impairment charges related to logistics technology, each of which was determined to have no future use, $2.5 million related to post-production expenses for closed facilities in North America, $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture, $2.0 million related to build-out costs for a new production site in the United Kingdom in our Europe reporting segment, and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement. (3) Except for non-deductible goodwill impairments, adjustments to net income (loss) from continuing operations and adjusted net income (loss) per share from continuing operations are tax-effected using the applicable jurisdictional statutory tax rate. (4) Tax special items for the three and nine months ended September 26, 2026, primarily included nominal tax expense and $3.2 mil lion of tax expense, respectively, attributable to domestic share-based compensation, fully offset by a nominal tax benefit and $3.2 million of tax benefit, respectively, related to the valuation allowance recorded against our U.S. tax attributes, and tax expense of $0.3 million and $1.4 million, respectively, due to changes in UTPs from ongoing audits. Tax special items for the three and nine months ended September 27, 2025, were primarily driven by valuation expense recorded against our U.S. tax attributes of $115.0 million and $129.2 million, respectively. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Page 24
Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions (1) Net legal and professional expenses and settlements include non-recurring transformation journey expenses of $1.7 million and $5.8 million in the three and nine months ended September 26, 2026, respectively, and $5.3 million and $24.6 million in the three and nine months ended September 27, 2025, respectively. The amount for the nine months ended September 26, 2026, includes $1.2 million related to a structural-pricing initiative in Europe. These expenses primarily relate to discrete project -based consulting fees that directly support the Company’s transformation journey and are not expected to represent normal, recurring operating expenses. These projects include the centralization of human resources processes, North America supply chain network optimization strategy, and other projects related to our transform ation journey. These expenses also include $2.5 million for the nine months ended September 27, 2025, related to the engagement of a transformation consultant for a period spanning from the third quarter of 2023 through April 2025. Additionally, net legal and professional expenses and se ttlements include $0.4 million and $10.0 million in the three and nine months ended September 26, 2026, respectively, and $0.4 million in both the three and nine months ended September 27, 2025, relating to litigation of historical legal matters. (2) Goodwill impairment consists of a prior year goodwill impairment charge associated with our North America and Europe reportin g units. (3) Restructuring and asset-related charges, net represents severance, accelerated depreciation and amortization, equipment relocati on and other expenses directly incurred as a result of restructuring events. The restructuring charges primarily relate to ch arges incurred to change the operating structure, eliminate certain roles, and close certain manufacturing facilities in our North America and Europe segments. (4) Product and inventory-related charges represent charges associated with announced facility closures, including product -related cash charges recorded as a reduction of net revenues and inventory and other product -related non-cash charges recorded in cost of sales. These amounts are excluded from Adjusted EBITDA from continuing operations. (5) M&A related costs, net consist of legal and professional expenses related to strategic initiatives and the court -ordered divestiture of Towanda. (6) Net gain on sale of business, property, and equipment in the three and nine months ended September 26, 2026, primarily relate s to the sale of our business in Hawaii and the sale of property in Denmark. Net gain on sale of business, property, and equipme nt in the nine months ended September 27, 2025, primarily relates to the court -ordered divestiture of Towanda and the sale of property and equipment in Mari on, North Carolina. (7) Loss on extinguishment and refinancing of debt consists of $0.2 million in the nine months ended September 27, 2025, associated with an amendment of our ABL Facility. (8) Share-based compensation expense represents equity-based compensation expense related to the issuance of share -based awards. (9) Other special items not core to ongoing business activity include: (i) for the three months ended September 26, 2026 , impairment charges of $2.5 million recognized in connection with the Company’s North America equipment capacity optimization rev iew and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement.; (ii) for the ni ne months ended September 26, 2026, impairment charges of $5.6 million recognized in connection with the Company’s North America eq uipment capacity optimization review, $3.0 million of impairment and other related charges related to windows manufacturing technology, and $1.8 million of im pairment charges related to logistics technology, each of which was determined to have no future use, $2.5 million related to post-production expenses for closed facilities in North America, $1.2 million related to costs incurred to fulfill production capability requirements associated wit h the court-ordered Towanda divestiture, $2.0 million related to build-out costs for a new production site in the United Kingdom in our Europe reporting segment, and a $1.0million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangeme nt. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended Nine Months Ended (amounts in millions) September 26, 2026 September 27, 2025 September 26, 2026 September 27, 2025 Loss from continuing operations, net of tax $ (17.2) $ (367.6) $ (125.6) $ (580.0) Income tax expense 2.9 148.7 10.9 145.9 Depreciation and amortization 28.0 28.3 86.3 83.0 Interest expense, net 19.5 17.4 55.0 48.8 Special items: Net legal and professional expenses and settlements(1) 1.3 5.8 16.9 26.3 Goodwill impairment(2) — 196.9 — 334.6 Restructuring and asset-related charges, net(3)(4) 12.7 8.8 18.7 32.2 M&A related costs, net(5) (2.4) 2.4 8.6 1.9 Net gain on sale of business, property, and equipment(6) (0.1) — (0.1) (2.8) Loss on extinguishment and refinancing of debt(7) — — — 0.2 Share-based compensation expense(8) 4.2 4.3 11.6 11.9 Other special items(9) 5.8 (0.6) 20.6 3.3 Adjusted EBITDA from continuing operations $ 54.4 $ 44.4 $ 102.9 $ 105.3 24
Page 25
(1) Refer to the calculation of Adjusted EBITDA for a discussion of the Special items listed earlier in this presentation. (2) Other special items primarily include impairment charges of $2.5million recognized in connection with the Company’s North America equipment capacity optimization review and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended September 26, 2026 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss), net of tax $ 21.2 $ (6.9) $ (31.5) $ (17.2) Income tax (benefit) expense 0.3 2.6 (0.1) 2.9 Depreciation and amortization 17.4 8.2 2.4 28.0 Interest expense, net 0.1 1.7 17.7 19.5 Special items:(1) Net legal and professional expenses and settlements 0.2 1.0 0.1 1.3 Restructuring and asset-related charges, net 4.4 8.2 — 12.7 M&A related costs, net — — (2.4) (2.4) Net loss (gain) on sale of business, property, and equipment 0.9 (1.1) — (0.1) Share-based compensation expense 0.4 0.6 3.2 4.2 Other special items(2) 3.3 0.6 1.8 5.8 Adjusted EBITDA $ 48.3 $ 15.0 $ (8.9) $ 54.4 25 USD in Millions Q3 2026 QTD Segment Adjusted EBITDA Reconciliation
Page 26
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended September 27, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss from continuing operations, net of tax $ (181.3) $ (153.4) $ (33.0) $ (367.6) Income tax expense (benefit) 151.9 0.4 (3.6) 148.7 Depreciation and amortization 17.3 8.5 2.5 28.3 Interest expense, net 0.2 1.0 16.2 17.4 Special items:(1) Net legal and professional expenses and settlements 1.1 1.5 3.1 5.8 Goodwill impairment 43.5 153.4 — 196.9 Restructuring and asset-related charges, net 3.9 3.9 1.0 8.8 M&A related costs, net — — 2.4 2.4 Share-based compensation expense 0.6 0.7 3.0 4.3 Other special items 0.3 — (0.9) (0.6) Adjusted EBITDA from continuing operations $ 37.7 $ 16.0 $ (9.3) $ 44.4 26 USD in Millions Q3 2025 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 27
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed in the Q2 2026 earnings presentation. (2) North America other special items include impairment charges of $2.7 million related to windows manufacturing technology, and $1.8 million related to logistics technology, each of which was determined to have no future use, and $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Three Months Ended June 27, 2026 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss) from continuing operations, net of tax $ 26.9 $ (3.4) $ (55.0) $ (31.5) Income tax (benefit) expense (12.0) 3.8 12.8 4.6 Depreciation and amortization 18.4 8.2 2.4 29.0 Interest expense, net 0.1 1.0 17.3 18.4 Special items:(1) Net legal and professional expenses and settlements 0.2 0.5 2.2 2.8 Restructuring and asset-related charges, net 1.6 2.1 0.4 4.1 M&A related costs, net — — 3.4 3.4 Share-based compensation expense 0.7 0.4 2.7 3.7 Other special items(2) 4.8 0.7 2.4 7.8 Adjusted EBITDA from continuing operations $ 40.7 $ 13.2 $ (11.6) $ 42.3 27 USD in Millions Q2 2026 QTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 28
(1) Refer to the calculation of Adjusted EBITDA for a discussion of the Special items listed earlier in this presentation. (2) Other special items primarily include impairment charges of $5.6million recognized in connection with the Company’s North America equipment capacity optimization review, $3.0 million of impairment and other related charges related to windows manufacturing technology, and $1.8 million of impairment charges related to logistics technology, each of which was determined to have no future use, $2.5 million related to post-production expenses for closed facilities in North America, $1.2 million related to costs incurred to fulfill production capability requirements associated with the court-ordered Towanda divestiture, $2.0 million related to build-out costs for a new production site in the United Kingdom in our Europe reporting segment, and a $1.0 million charge in Corporate and unallocated costs related to the termination of the Company’s fractional aircraft arrangement. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Nine Months Ended September 26, 2026 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Income (loss), net of tax $ 13.1 $ (20.4) $ (118.3) $ (125.6) Income tax expense (benefit) 1.9 9.2 (0.2) 10.9 Depreciation and amortization 54.6 24.9 6.9 86.3 Interest (income) expense, net (0.3) 3.4 51.9 55.0 Special items:(1) Net legal and professional expenses and settlements 0.5 3.5 12.9 16.9 Restructuring and asset-related charges, net 6.9 11.4 0.4 18.7 M&A related costs, net — — 8.6 8.6 Net loss (gain) on sale of business, property, and equipment 0.9 (1.1) — (0.1) Share-based compensation expense 1.8 1.5 8.4 11.6 Other special items(2) 13.2 2.8 4.6 20.6 Adjusted EBITDA $ 92.6 $ 35.3 $ (25.0) $ 102.9 28 USD in Millions Q3 2026 YTD Segment Adjusted EBITDA Reconciliation
Page 29
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Nine Months Ended September 27, 2025 (amounts in millions) North America Europe Corporate and Unallocated Costs Total Consolidated Loss from continuing operations, net of tax $ (333.6) $ (160.8) $ (85.7) $ (580.0) Income tax expense (benefit) 166.5 6.8 (27.5) 145.9 Depreciation and amortization 51.4 24.3 7.4 83.0 Interest (income) expense, net (1.0) 2.6 47.2 48.8 Special items:(1) Net legal and professional expenses and settlements 2.6 4.3 19.4 26.3 Goodwill impairment 181.2 153.4 — 334.6 Restructuring and asset-related charges, net 19.0 11.5 1.7 32.2 M&A related costs, net — — 1.9 1.9 Net gain on sale of business, property, and equipment (2.8) — — (2.8) Loss on extinguishment and refinancing of debt — — 0.2 0.2 Share-based compensation expense 2.1 1.7 8.1 11.9 Other special items 2.3 0.1 0.9 3.3 Adjusted EBITDA from continuing operations $ 87.9 $ 43.7 $ (26.4) $ 105.3 29 USD in Millions Q3 2025 YTD Segment Adjusted EBITDA From Continuing Operations Reconciliation
Page 30
(1) Refer to the calculation of Adjusted EBITDA from continuing operations for a discussion of the Special items listed earlier in this presentation. Due to rounding, numbers presented may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures. Trailing Twelve Months Ended (amounts in millions) September 26, 2026 December 31, 2025 Loss from continuing operations, net of tax $ (167.8) $ (622.2) Income tax expense 12.9 147.9 Depreciation and amortization 115.7 112.4 Interest expense, net 73.4 67.2 Special items:(1) Net legal and professional expenses and settlements 22.0 31.5 Goodwill impairment — 334.6 Restructuring and asset-related charges, net 31.0 44.5 M&A related costs, net 15.7 9.1 Net gain on sale of business, property and equipment (34.5) (37.1) Loss on extinguishment and refinancing of debt — 0.2 Share-based compensation expense 14.7 15.0 Pension settlement charge 6.6 6.6 Other special items 25.7 8.4 Adjusted EBITDA from continuing operations $ 115.5 $ 118.0 30 Q3 2026 TTM Adjusted EBITDA From Continuing Operations Reconciliation USD in Millions